Dental implants osseointegration in patients with osteoporosis

Cover Page

Cite item

Abstract

The successful use of surgical and medical methods of jaw bone tissue restoration has been convincingly confirmed in clinical practice. At the same time, technologies are being developed to improve the osseointegration of dental implants in patients with osteoporosis. The use of various implant coatings, as well as systemic therapy, demonstrate the emergence of new directions in the treatment of patients with partial or complete secondary edentulism with concomitant osteoporosis. This trend is relevant in modern medicine . Information was obtained from the PubMed database, using the keywords «osteoporosis» and «osseointegration» and «dental implantation» and «zoledronic acid» from 2016 to 2022. Articles were selected based on experimental work. Numerous studies have shown that bone tissue is an effective indicator of osteoporotic changes. The main changes in bone tissue in osteoporosis are emphasized - a decrease in bone volume, deterioration of the microarchitecture of the trabecular bone and processes that prevent osseointegration - loss of bone mass, a significant decrease in the percentage of contact in the implant-bone complex. Methods of dealing with the negative impact on the operation of dental implantation have been identified. In a review of studies on the systemic administration of drugs based on bisphosphonates, an increase in the osseointegration of dental implants was revealed, the systemic administration of zoledronic acid preparations significantly increased the formation of new bone, which in turn contributed to the elimination of such a negative effect of osteoporosis as bone resorption. In addition to the systemic administration of bisphosphonates, experimental studies describe the topical application of bisphosphonates in the form of various implant coatings. Topical application of bisphosphonates also contributed to increased osseointegration. Microstructured coated implants showed less marginal bone loss compared to uncoated implants. Conclusion. The use of dental implants with modified macro- and microrelief, as well as systemic drug therapy, remains the main direction of scientific research that contributes to the optimization of osseointegration of dental implants.

About the authors

Marina H. Hammouri

Peoples’ Friendship University of Russia

Author for correspondence.
Email: dr.hmarina@gmail.com
ORCID iD: 0000-0002-0886-9160
Moscow, Russian Federation

Karina M. Salekh

Peoples’ Friendship University of Russia

Email: dr.hmarina@gmail.com
ORCID iD: 0000-0003-4415-766X
Moscow, Russian Federation

References

  1. Lu X, Yu S, Chen G. Insight into the roles of melatonin in bone tissue and bone - related diseases. Int J Mol Med. 2021;47(5):82. doi: 0.3892/ijmm.2021.4915
  2. Porter JL, Varacallo M. Osteoporosis. Treasure Island (FL): StatPearls Publishing. 2022. 238 p.
  3. Li Y, Ling J, Jiang Q. Inflammasomes in Alveolar Bone Loss. Front Immunol. 2021;12:691013. doi: 10.3389/fimmu.2021.691013.
  4. Zhao B, Li X, Xu H. Influence of Simvastatin-StrontiumHydroxyapatite Coated Implant Formed by Micro-Arc Oxidation and Immersion Method on Osteointegration in Osteoporotic Rabbits. Int J Nanomedicine. 2020;15:1797-1807. doi: 10.2147/IJN.S244815
  5. Lee JWY, Bance ML. Physiology of Osseointegration. Otolaryngol Clin North Am. 2019;52(2):231-242.
  6. Takahashi T, Watanabe T, Nakada H. Effect of a dietary supplement on peri-Implant bone strength in a rat model of osteoporosis. J Prosthodont Res. 2016;60(2):131-7. doi: 10.1016/j.jpor.2015.12.006.
  7. Jonasson G, Rythén M. Alveolar bone loss in osteoporosis: a loaded and cellular affair?. Clin Cosmet Investig Dent. 2016;8:95-103. doi: 10.2147/CCIDE.S 92774
  8. Jiang L, Shen X, Wei L. Effects of bisphosphonates on mandibular condyle of ovariectomized osteoporotic rats using micro -ct and histomorphometric analysis. J Oral Pathol Med. 2017;46(5):398-404. doi: 10.1111/jop.12499
  9. Alam T, AlShahrani I, Assiri KI. Evaluation of Clinical and Radiographic Parameters as Dental Indicators for Postmenopausal Osteoporosis. Oral Health Prev Dent. 2020;18(1):499-504. doi: 10.3290/j.ohpd.a44688
  10. Chen X, Moriyama Y, Takemura Y. Influence of osteoporosis and mechanical loading on bone around osseointegrated dental implants: A rodent study. J Mech Behav Biomed Mater. 2021;123:104771. doi: 10.1016/j.jmbbm.2021.104771
  11. Anderson KD, Ko FC, Virdi AS. Biomechanics of Implant Fixation in Osteoporotic Bone. Curr Osteoporos Rep. 2020;18(5):577 doi: 10.1007/s11914-020-00614-2
  12. McGrath C, Bedi R. The importance of oral health to older people’s quality of life. Gerodontology. 1999;16(1):59-63.
  13. Howson CP. Perspectives and needs for health in the 21st century: 20th-century paradigms in 21st-century science. J Hum Virol. 2000;3(2):94-103.
  14. Wang YN, Jia TT, Xu X, Zhang DJ. Overview of animal researches about the effects of systemic drugs on implant osseointegration. Hua Xi Kou Qiang Yi Xue Za Zhi. 2021;38(2):211 doi: 10.7518/hxkq.2020.02.017
  15. Kocijan R, Klaushofer K, Misof BM. Osteoporosis Therapeutics 2020. Handb Exp Pharmacol. 2020;262:397-422.
  16. Guglielmotti MB, Olmedo DG, Cabrini RL. Research on implants and osseointegration. Periodontol. 2019;79(1):178-189.
  17. Zhang X, Xu X, Liu X. Bis-enoxacin blocks alveolar bone resorption in rats with ovariectomy-induced osteoporosis. Mol Med Rep. 2018;17(2):3232-3238. doi: 10.3892/mmr.2017.8223
  18. Alghamdi HS, Jansen JA. The development and future of dental implants. Dent Mater J. 2020;39(2):167-172. doi: 10.4012/dmj.2019-140
  19. Barnsley J, Buckland G, Chan PE. Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people. Aging Clin Exp Res. 2021;33(4):759-773. doi: 10.1007/s40520-021-01817-y
  20. Schimmel M, Srinivasan M, McKenna G. Effect of advanced age and/or systemic medical conditions on dental implant survival: A systematic review and meta-analysis. Clin Oral Implants Res. 2018;16:311-330. doi: 10.1111/clr.13288
  21. Sher J, Kirkham-Ali K, Luo JD. Dental Implant Placement in Patients with a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review. J Oral Implantol. 2021;47(3):249-268. doi: 10.1563/aaid-joi-D-19-00351
  22. He B, Zhao JQ, Zhang MZ. Zoledronic acid and fracture risk: a meta-analysis of 12 randomized controlled trials. Eur Rev Med Pharmacol Sci. 2021;25(3):1564-1573. doi: 10.26355/eurrev_202102_24865
  23. Demircan S, Isler SC. Histopathological Examination of the Effects of Local and Systemic Bisphosphonate Usage in Bone Graft Applications on Bone Healing. J Maxillofac Oral Surg. 2021;20(1):144-148. doi: 10.1007/s12663-020-01335-w
  24. Sokmen N, Dundar S, Bozoglan. Effect of Primary Stabilisation on Osseointegration of Implants with Local and Systemic Zoledronic Acid Application. J Craniofac Surg. 2021. doi: 10.1097/ SCS.0000000000008236
  25. De Oliveira MA, Asahi DA, Silveira CAE. The effects of zoledronic acid and dexamethasone on osseointegration of endosseous implants: histological and histomorphometrical evaluation in rats. Clin Oral Implants Res. 2015;26(4): e17-e21. doi: 10.1111/clr.12335
  26. Barnsley J, Buckland G, Chan PE. Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people. Aging Clin Exp Res. 2021;33(4):759-773. doi: 10.1007/s40520-021-01817-y
  27. Lotz EM, Cohen DJ, Ellis RA. Ibandronate Treatment Before and After Implant Insertion Impairs Osseointegration in Aged Rats with Ovariectomy Induced Osteoporosis. JBMR Plus. 2019;3(7): e10184. doi: 10.1002/jbm4.10184
  28. Mardas N, Busetti J, de Figueiredo JA. Guided bone regeneration in osteoporotic conditions following treatment with zoledronic acid. Clin Oral Implants Res. 2017;28(3):362-371. doi: 10.1111/clr.12810
  29. Dikicier S, Dikicier E, Karacayli U. Radiodensitometric study for evaluation of bone mineral density around dental implants after zoledronic acid treatment in ovariectomized rats. Med Oral Patol Oral Cir Bucal. 2017;22(3): e377 - e382. doi: 10.4317/medoral.21706
  30. Kozlova MV, Mkrtumyan AM, Bazikyan EA. Effect of dental implants with conditioned surface based on sodium hydroxide in patients with osteoporosis. Stomatologiia (Mosk). 2019;98(3):46-51. (In Russ.). doi: 10.17116/stomat20199803146
  31. Steller D, Herbst N, Pries R. Impacts of platelet-rich fibrin and platelet-rich plasma on primary osteoblast adhesion onto titanium implants in a bisphosphonate in vitro model. J Oral Pathol Med. 2019;48(10):943-950. doi: 10.1111/jop.12944
  32. Korn P, Kramer I, Schlottig F. Systemic sclerostin antibody treatment increases osseointegration and biomechanical competence of zoledronic-acid-coated dental implants in a rat osteoporosis model. Eur Cell Mater. 2019;37:333-346. doi: 10.22203/eCM.v037a20
  33. Kellesarian SV, Subhi ALHarthi S, Saleh Binshabaib M. Effect of local zoledronate delivery on osseointegration: a systematic review of preclinical studies. Acta Odontol Scand. 2017;75(7):530-541. doi: 10.1080/00016357.2017.1350994
  34. Abtahi J, Henefalk G, Aspenberg P. Impact of a zoledronate coating on early post-surgical implant stability and marginal bone resorption in the maxilla-A split-mouth randomized clinical trial. Clin Oral Implants Res. 2019;30(1):49-58. doi: 10.1111/clr.13391
  35. Ghanem A, Kellesarian SV, Abduljabbar T. Role of Osteogenic Coatings on Implant Surfaces in Promoting Bone-To-Implant Contact in Experimental Osteoporosis: A Systematic Review and Meta-Analysis. Implant Dent. 2017;26(5):770-777. doi: 10.1097/ID.0000000000000634
  36. Maiquan W, Liwei P, Yunfeng L. Efficacy of systemic administration of oxytocin on implant osseointegration in osteoporotic rats. Hua Xi Kou Qiang Yi Xue Za Zhi. 2016;34(4):332-335. (In Chinese). doi: 10.7518/hxkq.2016.04.002

Copyright (c) 2022 Hammouri M.H., Salekh K.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies